144 related articles for article (PubMed ID: 7579355)
21. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster.
Aguiar RC; Sill H; Goldman JM; Cross NC
Leukemia; 1997 Feb; 11(2):233-8. PubMed ID: 9009086
[TBL] [Abstract][Full Text] [Related]
22. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
[TBL] [Abstract][Full Text] [Related]
23. Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia.
Montpetit A; Larose J; Boily G; Langlois S; Trudel N; Sinnett D
Leukemia; 2004 Sep; 18(9):1499-504. PubMed ID: 15284860
[TBL] [Abstract][Full Text] [Related]
24. Homozygous deletions at 9p21 in childhood acute lymphoblastic leukemia detected by microsatellite analysis.
Takeuchi S; Koike M; Seriu T; Bartram CR; Slater J; Park S; Miyoshi I; Koeffler HP
Leukemia; 1997 Oct; 11(10):1636-40. PubMed ID: 9324282
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the human cyclin-dependent kinase inhibitor p27kip1 in primary breast carcinomas.
Ferrando AA; Balbín M; Pendás AM; Vizoso F; Velasco G; López-Otín C
Hum Genet; 1996 Jan; 97(1):91-4. PubMed ID: 8557269
[TBL] [Abstract][Full Text] [Related]
26. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in paediatric acute lymphoblastic leukaemias.
Guidal-Giroux C; Gérard B; Cavé H; Duval M; Rohrlich P; Elion J; Vilmer E; Grandchamp B
Br J Haematol; 1996 Feb; 92(2):410-9. PubMed ID: 8603008
[TBL] [Abstract][Full Text] [Related]
27. Frequent loss of heterozygosity on the long arm of chromosome 6: identification of two distinct regions of deletion in childhood acute lymphoblastic leukemia.
Takeuchi S; Koike M; Seriu T; Bartram CR; Schrappe M; Reiter A; Park S; Taub HE; Kubonishi I; Miyoshi I; Koeffler HP
Cancer Res; 1998 Jun; 58(12):2618-23. PubMed ID: 9635588
[TBL] [Abstract][Full Text] [Related]
28. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
29. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
Ragione FD; Iolascon A
Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
[TBL] [Abstract][Full Text] [Related]
30. p16 gene homozygous deletions in acute lymphoblastic leukemia.
Quesnel B; Preudhomme C; Philippe N; Vanrumbeke M; Dervite I; Lai JL; Bauters F; Wattel E; Fenaux P
Blood; 1995 Feb; 85(3):657-63. PubMed ID: 7833469
[TBL] [Abstract][Full Text] [Related]
31. Allelotype analysis of childhood acute lymphoblastic leukemia.
Takeuchi S; Bartram CR; Wada M; Reiter A; Hatta Y; Seriu T; Lee E; Miller CW; Miyoshi I; Koeffler HP
Cancer Res; 1995 Nov; 55(22):5377-82. PubMed ID: 7585604
[TBL] [Abstract][Full Text] [Related]
32. Inverse correlation between loss of heterozygosity of the short arm of chromosome 12 and p15ink4B/p16ink4 gene inactivation in childhood acute lymphoblastic leukaemia.
Heyman M; Calero Moreno T; Liu Y; Grandér D; Rasool O; Borgonova-Brandter L; Merup M; Söderhäll S; Einhorn S
Br J Haematol; 1997 Jul; 98(1):147-50. PubMed ID: 9233578
[TBL] [Abstract][Full Text] [Related]
33. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines.
Kim DH; Moldwin RL; Vignon C; Bohlander SK; Suto Y; Giordano L; Gupta R; Fears S; Nucifora G; Rowley JD
Blood; 1996 Aug; 88(3):785-94. PubMed ID: 8704231
[TBL] [Abstract][Full Text] [Related]
34. p16ink4a gene and hematological malignancies.
Quesnel B; Preudhomme C; Fenaux P
Leuk Lymphoma; 1996 Jun; 22(1-2):11-24. PubMed ID: 8724524
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
36. Identification of oncogenes collaborating with p27Kip1 loss by insertional mutagenesis and high-throughput insertion site analysis.
Hwang HC; Martins CP; Bronkhorst Y; Randel E; Berns A; Fero M; Clurman BE
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11293-8. PubMed ID: 12151601
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the cyclin-dependent kinase inhibitor p27Kip1 in muscle invasive bladder cancer.
Serth J; Kuczyk M; Machtens S; Bokemeyer C; Herrmann R; Hartmann J; Knüchel R; Jonas U
Oncol Rep; 1999; 6(1):229-33. PubMed ID: 9864434
[TBL] [Abstract][Full Text] [Related]
38. p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors.
Ponce-Castañeda MV; Lee MH; Latres E; Polyak K; Lacombe L; Montgomery K; Mathew S; Krauter K; Sheinfeld J; Massague J
Cancer Res; 1995 Mar; 55(6):1211-4. PubMed ID: 7882310
[TBL] [Abstract][Full Text] [Related]
39. Refined mapping of genomic rearrangements involving the short arm of chromosome 9 in acute lymphoblastic leukemias and other hematologic malignancies.
Dreyling MH; Bohlander SK; Le Beau MM; Olopade OI
Blood; 1995 Sep; 86(5):1931-8. PubMed ID: 7544647
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1.
Kwon TK; Nagel JE; Buchholz MA; Nordin AA
Gene; 1996 Nov; 180(1-2):113-20. PubMed ID: 8973354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
